Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 131 entries
View as:

A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05951946 Org: User:
Start: 07/22/23 End: 09/11/23 Due: 09/11/24

NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis

Phase: N/A Priority: Normal
NCT ID: NCT04131686 Org: User:
Start: 09/30/19 End: 09/17/21 Due: 09/17/22

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00937534 Org: User:
Start: 01/31/09 End: 08/31/09 Due: 08/31/10

Fimasartan Achieving SBP Target (FAST) Study

Phase: N/A Priority: Normal
NCT ID: NCT02495324 Org: User:
Start: 06/30/15 End: 05/31/17 Due: 05/31/18

Fimasartan/Amlodipine Combination Phase III

Phase: N/A Priority: Normal
NCT ID: NCT02152306 Org: User:
Start: 04/30/14 End: 07/31/15 Due: 07/31/16

A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06879132 Org: User:
Start: 11/05/24 End: 12/07/24 Due: 12/07/25

Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study

Phase: N/A Priority: Normal
NCT ID: NCT03254914 Org: User:
Start: 08/09/17 End: 02/28/19 Due: 02/28/20

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02920047 Org: User:
Start: 10/31/16 End: 01/31/17 Due: 01/31/18

A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05875259 Org: User:
Start: 05/13/23 End: 06/29/23 Due: 06/29/24

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00991783 Org: User:
Start: 08/31/09 End: 11/30/09 Due: 11/30/10

Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion

Phase: N/A Priority: Normal
NCT ID: NCT02022774 Org: User:
Start: 04/30/12 End: 06/30/17 Due: 06/30/18

A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06890299 Org: User:
Start: 12/05/24 End: 01/12/25 Due: 01/12/26

A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT03338426 Org: User:
Start: 01/15/18 End: 04/22/19 Due: 04/22/20

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06821945 Org: User:
Start: 02/28/25 End: 05/31/27 Due: 05/31/28

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00938132 Org: User:
Start: 07/31/09 End: 09/30/09 Due: 09/30/10

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT02569814 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06879158 Org: User:
Start: 11/10/24 End: 01/26/25 Due: 01/26/26

A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06537752 Org: User:
Start: 07/15/24 End: 10/31/26 Due: 10/31/27

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01878201 Org: User:
Start: 05/31/13 End: 02/28/14 Due: 02/28/15

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor

Phase: N/A Priority: Normal
NCT ID: NCT04545632 Org: User:
Start: 06/10/20 End: 06/24/21 Due: 06/24/22

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administration of "BR1017-1A" and "BR1017-1B"

Phase: N/A Priority: Normal
NCT ID: NCT06184269 Org: User:
Start: 12/23/23 End: 02/18/24 Due: 02/18/25

An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe

Phase: N/A Priority: Normal
NCT ID: NCT05559606 Org: User:
Start: 09/07/22 End: 06/30/25 Due: 06/30/26

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Phase: N/A Priority: Normal
NCT ID: NCT06226727 Org: User:
Start: 02/14/24 End: 03/31/24 Due: 03/31/25

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02581696 Org: User:
Start: 08/31/15 End: 11/30/15 Due: 11/30/16

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02759224 Org: User:
Start: 04/15/16 End: 12/29/16 Due: 12/29/17